B
CVS icon

Bayban’s CVS Health CVS Stock Holding History

Bayban’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.9K Hold
801
– – 0.06% 181
2026
Q1 		$57.5K Sell
801
-10
-1% -$770 0.05% 223
2025
Q4 		$64.4K Buy
+811
New +$63.9K 0.06% 202

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bayban's CVS Position: Q2 2026 in Review

Bayban held its CVS Health (CVS) position steady in Q2 2026 at 801 shares worth $82.9K. The position accounts for 0.06% of the portfolio, ranked #181.

Bayban first reported a position in CVS in Q4 2025 and has held it in 3 quarters since. 1,975 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bayban held 801 shares of CVS Health worth $82.9K as of Q2 2026.
  • Bayban left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.06% of Bayban's portfolio in Q2 2026, its #181 holding.
  • Bayban first reported a position in CVS Health in Q4 2025 and has held it in 3 quarters since.
  • 1,975 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.